✦ LIBER ✦

Guidelines to Practice Gap in the Use of Glycoprotein IIb/IIIa Inhibitors: From ISAR-REACT to Overreact?

✍ Scribed by G. VISWANATHAN; S. JAVED; G. MAYURATHAN; S. SALLEHUDDIN; S. JAMIESON; A. G. ZAMAN

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prospective analysis of complications

✍ RM Rocha,CT Mesquita,MCFS Kanto,FS Lugão,AL Cascardo,PS Lira… 📂 Article 📅 2001 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 831 KB

Trials of glycoprotein IIb-IIIa inhibito

✍ W. W. Parmley 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

878-3 Subgroup analysis of the impact of

✍ Peter B Berger; Adnan Kastrati; Julinda Mehilli; Helmut Schuhlen; Josef Dirschin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Decreased complication rates using the t

✍ Jonas Eichhöfer; Eric Horlick; Joan Ivanov; Peter H. Seidelin; John R. Ross; Dou 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Efficacy and Safety of Fondaparinux Vers

✍ Sanjit S. Jolly; David P. Faxon; Keith A.A. Fox; Rizwan Afzal; William E. Boden; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 847 KB

Optimizing the pharmacoinvasive approach

✍ Pantila Vanichakarn; Rayson C. Yang; Sheila M. Conley; Tamara A. Anderson; James 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 159 KB